derivatization with fatty acids in peptide and protein drug discovery methods for ligation or derivatization of peptides - Ispeptidetherapy FDA approved methods for ligation or derivatization of peptides Derivatization with Fatty Acids: Enhancing Peptide and Protein Therapeutics in Drug Discovery

Derivatization with fatty acids in peptide and protein drug discoverykurtzhals et al The field of peptide and protein drug discovery is increasingly leveraging the strategic modification of therapeutic molecules through derivatization with fatty acidsTrends inpeptide drug discovery. Nat. Rev. Drug Discov. 20, 309–325 (2021). This Review focuses on the current and future aspects ofpeptide drug discovery.. This approach, often referred to as lipidation or fatty acid acylation, involves covalently attaching fatty acid chains to peptides and proteins. The primary goal of this modification is to enhance their pharmacokinetic and pharmacodynamic properties, thereby improving their therapeutic efficacy and patient convenienceFatty Acid Modified Peptide Synthesis. Fatty acid derivatization is a versatile strategy that offers significant advantages in developing next-generation peptide and protein drugs by influencing absorption, distribution, metabolism, and excretion.

The Rationale Behind Fatty Acid Derivatization

Peptide and protein drugs, while offering high specificity and potency, often suffer from poor oral bioavailability, rapid degradation by proteases, and short half-lives in circulation. These limitations necessitate frequent dosing, often via injection, which can impact patient adherence and overall treatment success. Fatty acid modification addresses these challenges by introducing lipophilic tails that can alter the drug's interaction with biological systems.

One of the key benefits of this derivatization is the ability to reduce the rate of absorption. By increasing the lipophilicity of the peptide or protein, fatty acid conjugation can promote binding to albumin, the most abundant protein in blood plasma.Fmoc Solid-Phase Peptide Synthesis This albumin binding acts as a reservoir, slowing down the drug's release into systemic circulation and extending its half-life.2025年7月4日—It highlights the utility offattyacid acylation to upgradepeptidesfromdrugmolecules with high potency and selectivity but poor ... Consequently, this can lead to less frequent dosing regimens, improving patient compliance and potentially reducing the overall cost of treatment.

Mechanisms and Advantages in Drug Development

The derivatization with fatty acids in peptide and protein drug discovery is primarily achieved through fatty acid acylation, where the carboxyl group of a fatty acid is linked to amino or hydroxyl groups on the peptide or protein. This covalent attachment can be performed at specific sites, allowing for precise control over the modificationSite-specific fatty acid-conjugation to prolong protein half- .... The choice of fatty acid chain length and structure can be tailored to optimize desired properties2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 .... For instance, longer fatty acid chains generally lead to greater albumin binding and a longer half-life, while shorter chains might offer different pharmacokinetic profiles.作者：M Ebbini·2025·被引用次数：3—We introduce a novel on-tissue chemicalderivatizationmethod for FAs using Girard's Reagent T (GT) as aderivatizationreagent combined with 2-chloro-1- ...

Beyond extending half-life, fatty acid derivatization can also influence cellular uptake and targetingCarboxylicacidscan be converted to esters, amides, acyl hydrazides or hydroxamicacids, all of which are discussed in this section.. The lipophilic nature of the attached fatty acid can facilitate interaction with cell membranes, potentially improving intracellular delivery of the therapeutic agent. Furthermore, the inherent safety and well-defined chemical nature of fatty acids make them attractive components for pharmaceutical development, minimizing concerns about toxicity associated with other types of modifications. This versatility makes peptide drug discovery a dynamic area, with lipidization emerging as a breakthrough strategyOn-Tissue Chemical Derivatization for Mass Spectrometry ....

Applications and Future Directions

The application of fatty acid derivatization spans various therapeutic areas where peptide and protein drugs are employed, including metabolic diseases, oncology, and infectious diseasesSoren Ostergaard (0000-0002-9415-3352). For example, modifications of GLP-1 receptor agonists with fatty acids have led to long-acting formulations for diabetes managementReviews & Analysis | Nature Reviews Drug Discovery. Similarly, fatty acid conjugation is being explored to enhance the delivery and efficacy of peptide-based cancer therapies.

The ongoing research in this domain focuses on developing more efficient and site-specific conjugation methods, exploring novel fatty acid structures, and understanding the complex interplay between the modified drug and biological systems. Advanced analytical techniques are crucial for characterizing these modified drugs and ensuring their quality and consistencyDerivatization and analysis of amino acids by hplc. As our understanding of lipid metabolism and protein interactions deepens, derivatization with fatty acids is poised to play an even more significant role in the development of safer, more effective, and patient-friendly peptide and protein therapeutics. The continuous evolution of peptide technology and drug discovery platforms will undoubtedly uncover new opportunities for this powerful modification strategy.